Please login to the form below
Intellectual property
This page shows the latest Intellectual property news and features for those working in and with pharma, biotech and healthcare.
WHO joins calls for equitable access to healthcare products ahead of future pandemics
The World Health Organization (WHO), World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO) have united in calls for cooperation regarding future pandemics, highlighting the importance of fostering innovation
Latest news
-
WHO, WIPO and WTO to hold technical symposium on pandemic preparedness
The World Health Organization (WHO), the World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO) have announced they will hold a joint technical symposium on 'COVID-19 Pandemic: Response, ... property and discuss the way
-
AstraZeneca and Medera’s Novoheart develop first human models of heart failure
Under the terms of the 2019 agreement, Novoheart exclusively owns the intellectual property rights to the newly developed model.
-
Kite and Refuge Biotechnologies join to develop potential treatments for blood cancer
Kite will have an exclusive licence to Refuge’s intellectual property portfolio for use in blood cancers, alongside a library of synthetic gene expression programmes for these indications.
-
First evidence-based guide launched to put patients at heart of digital innovations
as data privacy, intellectual property, inclusivity, reimbursement, usability and recruitment of patients for health technology entrepreneurs.
-
Cancer Research UK drives innovation with Cancer Research Horizons
partners. Additionally, Horizons will provide intellectual property advice, research commercialisation support and an entrepreneurial programme and £30m of seed funding to help tackle the translational gap.
More from news
Approximately 6 fully matching, plus 298 partially matching documents found.
Latest Intelligence
-
Integrating competitive intelligence into business development, licensing and M&A strategy
including research, clinical development, regulatory, intellectual property, market research and commercial assessment.
-
How can virtual pharma companies de-risk new product launches?
affairs. They also need access to broader business knowledge spanning financials, tax, legal, intellectual property tactics and commercial strategy.
-
Rethinking our approach to infectious disease preparedness
Deals keep the wheels of R&D turning, allowing early stage seed investors to get their money back when another business acquires that intellectual property or buys the company.
-
A snapshot of… Enterprise Therapeutics
However, the short-term uncertainty caused by Brexit makes planning more difficult and therefore introduces perceived risks in terms of costs, access to markets, protection of intellectual property and access to
-
Shanks v Unilever? Or David v Goliath?
He therefore launched an application for compensation in the United Kingdom Intellectual Property Office.
More from intelligence
Approximately 2 fully matching, plus 42 partially matching documents found.
Latest appointments
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Andrade mostly comes from a business development, management and intellectual property background within pharmaceutical and biotech,.
-
Tony de Fougerolles joins Evox Therapeutics as CEO
the company’s intellectual property estate.
-
IFPMA appoints Fumie Griego as assistant director general
and background in global affairs, including intellectual property protection, pricing, costs, value issues and health diplomacy.
-
Robocath appoints CEO
He will now oversee the clinical development and rollout of the R-One robot, as well as work to consolidate the firm's intellectual property and assets.
-
Chase adds former Allergan execs to leadership team
With its robust intellectual property, pharmaceutical assets and elegant development strategy, Chase has the opportunity to profoundly reshape the approach to the symptomatic treatment of Alzheimer's disease.
More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest from PMHub
-
Protecting Ownership of Technological & Pharmaceutical Innovation
Joshua Goldberg, Co-Managing Partner at Nath, Goldberg &Meyer, discusses key intellectual property issues and pitfalls in the digital health space, the importance of international patent protection, and why it’s
-
Blockchain for Tracking and Validating Medical Cannabis
Robert Galarza, CEO of TruTrace Technologies, Inc., dives into the use of blockchain technology for verifying medical cannabis products and protecting intellectual property.
-
It's out - so what?
intellectual property system for pharmaceuticals, setting up a new authority for health emergency response, strengthening security of supply in the EU, launching a group to steer cooperation between national authorities on
-
EU Pharmaceutical Strategy Roadmap
This includes making sure the EU creates the right environment for innovation by retaining incentives for industry and creating a competitive intellectual property framework.
-
Designing a global digital patient services platform
There was a variety of pre-existing service design capabilities, initiatives and intellectual property, but many were hidden from the local markets.
More from PMHub
Approximately 2 fully matching, plus 13 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- Europe’s cancer community publishes new report on transforming patient care
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- EU to revise pharmaceuticals law amid antibiotic shortages
- European MPs call for urgent action against antimicrobial resistance
- The role of medical communications in building credibility for healthtech
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
